KKR Genetic Disorder L.P., Ten Percent Owner at BridgeBio Pharma, holds 25.26M shares in BridgeBio Pharma (Ticker: BBIO). Most recently, KKR Genetic Disorder L.P. Sold $5,800,000 shares of BridgeBio Pharma on Sep 17, 2024 for an estimated value of 149.35M.
What is the percentage of profitable transactions made by KKR Genetic Disorder L.P.?
The percentage of profitable transactions made by KKR Genetic Disorder L.P. is 50%.
What is the average return per transaction made by KKR Genetic Disorder L.P.?
The average return per transaction made by KKR Genetic Disorder L.P. is -5.60%.
What stocks does KKR Genetic Disorder L.P. hold?
KKR Genetic Disorder L.P. holds: BBIO stocks.
What was KKR Genetic Disorder L.P.’s latest transaction?
KKR Genetic Disorder L.P. latest transaction was an Informative Sell of $149.35M.
What was KKR Genetic Disorder L.P.'s most profitable transaction?
KKR Genetic Disorder L.P.’s most profitable transaction was an Informative Sell of BBIO stock on February 17, 2021. The return on the trade was 87.00%.
What is KKR Genetic Disorder L.P.'s role in BridgeBio Pharma?
KKR Genetic Disorder L.P.'s role in BridgeBio Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.